Home › Trial NCT05807035
Autologous Tumour Vaccine Trial
- Trial IDNCT05807035
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorVaxine Pty Ltd
- Enrollment30
- Start date2023-02-10
- ConditionsSolid Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.